Try
Arcus Biosciences, Inc.
RCUSUnited States
40 filed reports · 406 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
40 reports · Mar 2018 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 12 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 26 | 3,499 | Mar 2018 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 8 | 3,257 | Dec 2018 to Dec 2025 |
| Current · 8-KSEC EDGAR | 6 | 12 | Mar 2025 to Jun 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 5, 2026 | 283 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 5, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 5, 2026 | 161 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 5, 2026 | 2 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 25, 2026 | 714 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 25, 2026 | 2 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Oct 28, 2025 | 188 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Oct 28, 2025 | 2 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 6, 2025 | 112 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 6, 2025 | 2 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 6, 2025 | 115 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 6, 2025 | 2 | Open |
Financial data
406 concepts · 6,768 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial389 concepts · 6,408 facts · Dec 2016 to Jul 2026
- Cash and cash equivalents at carrying value51 · Dec 2016 to Jun 2026
- Comprehensive income net of tax48 · Dec 2016 to Jun 2026
- Depreciation and amortization48 · Dec 2016 to Jun 2026
- General and administrative expense (US GAAP)48 · Dec 2016 to Jun 2026
- Increase decrease in accounts payable48 · Dec 2016 to Jun 2026
- Net cash provided by used in operating activities48 · Dec 2016 to Jun 2026
- Net income loss48 · Dec 2016 to Jun 2026
- Nonoperating income expense48 · Dec 2016 to Jun 2026
- Operating expenses (US GAAP)48 · Dec 2016 to Jun 2026
- Operating income loss48 · Dec 2016 to Jun 2026
- Other comprehensive income loss net of tax portion attributable to parent48 · Dec 2016 to Jun 2026
- Payments to acquire property plant and equipment48 · Dec 2016 to Jun 2026
- Research and development expense48 · Dec 2016 to Jun 2026
- Share based compensation48 · Dec 2016 to Jun 2026
- Stockholders equity (US GAAP)48 · Dec 2016 to Jun 2026
- Common stock par or stated value per share47 · Dec 2017 to Jun 2026
- Accounts payable current46 · Dec 2017 to Jun 2026
- Accrued research and development expenses46 · Dec 2017 to Jun 2026
- Assets46 · Dec 2017 to Jun 2026
- Assets current46 · Dec 2017 to Jun 2026
- Cash and cash equivalents fair value disclosure46 · Dec 2017 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations46 · Dec 2017 to Jun 2026
- Common stock shares authorized46 · Dec 2017 to Jun 2026
- Common stock shares issued46 · Dec 2017 to Jun 2026
Product2 concepts · 207 facts · Dec 2018 to Jun 2026
- Revenue167 · Dec 2018 to Jun 2026
- Revenue from related parties40 · Dec 2018 to Jun 2023
Segment12 concepts · 136 facts · Dec 2022 to Jun 2026
- Depreciation depletion and amortization14 · Dec 2022 to Jun 2026
- Labor and related expense14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Reportable segment14 · Dec 2022 to Jun 2026
- Revenue14 · Dec 2022 to Jun 2026
- Segment reporting other item amount14 · Dec 2022 to Jun 2026
- Income tax expense benefit12 · Dec 2022 to Dec 2025
- Operating lease impairment loss12 · Dec 2022 to Dec 2025
- Total Assets11 · Dec 2023 to Jun 2026
- Interest expense nonoperating9 · Dec 2022 to Jun 2026
- Impairment losses related to real estate partnerships4 · Dec 2022 to Dec 2025
- Interest income operating and nonoperating4 · Jun 2024 to Sep 2025
Guidance1 concepts · 12 facts · May 2025 to Aug 2026
- Revenue Guidance12 · May 2025 to Aug 2026
Geography2 concepts · 5 facts · Dec 2020 to Dec 2022
- Hayward, California3 · Dec 2020 to Dec 2022
- Brisbane, California2 · Dec 2020 to Dec 2021
Segments
348 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service22 members · 207 facts
- Other Collaboration Revenue43 · Dec 2019 to Jun 2026
- License And Development Services Revenue32 · Dec 2020 to Sep 2025
- Gilead Collaboration Access Rights14 · Dec 2020 to Jun 2024
- License14 · Dec 2018 to Dec 2021
- Gilead Collaboration License And RD Services13 · Dec 2021 to Jun 2024
- Collaboration12 · Dec 2018 to Sep 2021
- Taiho Collaboration Agreement12 · Dec 2018 to Sep 2021
- Gilead Access Rights11 · Sep 2020 to Sep 2022
- Taiho Collaboration RD Services11 · Dec 2021 to Jun 2024
- Taiho Access Rights10 · Dec 2019 to Sep 2022
- Taiho Collaboration Access Rights10 · Dec 2020 to Dec 2023
- License And Development Services7 · Dec 2023 to Jun 2026
- Gilead Collaboration License To Domvanalimab3 · Dec 2021 to Dec 2023
- Gilead License To Zimberelimab3 · Sep 2020 to Dec 2020
- License And Development Services For All Gilead Programs3 · Mar 2022 to Sep 2022
- Taiho Collaboration License To Domvanalimab3 · Dec 2021 to Dec 2023
- Development Services For All Gilead Programs1 · Dec 2021
- Gilead Collaboration License To Zimberelimab1 · Dec 2020
- Gilead License To Domvanalimab1 · Dec 2021
- Taiho License To Domvanalimab1 · Dec 2021
- Taiho License To Etrumadenant1 · Dec 2018
- Taiho License To Zimberelimab1 · Dec 2019
Statement business segments2 members · 136 facts
- Reportable125 · Dec 2022 to Jun 2026
- Reportable segment11 · Dec 2023 to Jun 2026
Statement geographical2 members · 5 facts
- Brisbane California4 · Dec 2020 to Dec 2022
- CA1 · Dec 2021
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.